CoChat

An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs

Sheridan, C, Brumatti, G, Elgendy, M, Brunet, M, Martin, S J · 2010 · Oncogene
Cited by 71

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2010.380

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Adrain C, Martin SJ . (2006). Cell biology. Double knockout blow for caspases. Science 311: 785–786. · doi:10.1126/science.1124154
  2. Alves NL, Derks IA, Berk E, Spijker R, van Lier RA, Eldering E . (2006). The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 24: 703–716. · DOI · Paper page
  3. Amran D, Sancho P, Fernandez C, Esteban D, Ramos AM, de Blas E et al. (2005). Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation. Biochim Biophys Acta 1743: 269–279. · doi:10.1016/j.bbamcr.2004.10.009
  4. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME . (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286: 1358–1362. · DOI · Paper page
  5. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T et al. (2001). BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705–711. · DOI · Paper page
  6. Choi SS, Park IC, Yun JW, Sung YC, Hong SI, Shin HS . (1995). A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693–1698.
  7. Cosaert J, Quoix E . (2002). Platinum drugs in the treatment of non-small-cell lung cancer. Br J Cancer 87: 825–833. · DOI
  8. Dhomen N, Marais R . (2007). New insight into BRAF mutations in cancer. Curr Opin Genet Dev 17: 31–39. · DOI · Paper page
  9. Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari Jr AW et al. (2005). Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65: 6294–6304. · DOI · Paper page
  10. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M et al. (1999). The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806–809. · DOI · Paper page
  11. Hao D, Ritter MA, Oliver T, Browman GP . (2006). Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Semin Radiat Oncol 16: 10–19. · DOI
  12. Kim GP, Erlichman C . (2007). Oxaliplatin in the treatment of colorectal cancer. Expert Opin Drug Metab Toxicol 3: 281–294. · DOI
  13. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH . (2004). BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199: 113–124. · DOI · Paper page
  14. Kolch W . (2005). Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6: 827–837. · DOI · Paper page
  15. Labi V, Erlacher M, Kiessling S, Villunger A . (2006). BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 13: 1325–1338. · DOI · Paper page
  16. Lennon SV, Martin SJ, Cotter TG . (1991). Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24: 203–214. · DOI · Paper page
  17. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ . (2003). Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 278: 18811–18816. · DOI · Paper page
  18. Martin SJ, Cotter TG . (1990). Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL-60 cells. Cell Tissue Kinet 23: 545–559.
  19. Martin SJ, Green DR . (1994). Apoptosis as a goal of cancer therapy. Curr Opin Oncol 6: 616–621. · DOI
  20. Muggia F . (2009). Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol 112: 275–281. · DOI · Paper page
  21. Nguyen M, Marcellus RC, Roulston A, Watson M, Serfass L, Murthy Madiraju SR et al. (2007). Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci USA 104: 19512–19517. · DOI · Paper page
  22. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. (2003). Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17: 1475–1486. · DOI · Paper page
  23. Nikiforov MA, Riblett M, Tang WH, Gratchouck V, Zhuang D, Fernandez Y et al. (2007). Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc Natl Acad Sci USA 104: 19488–19493. · DOI · Paper page
  24. O'Reilly LA, Kruse EA, Puthalakath H, Kelly PN, Kaufmann T, Huang DC et al. (2009). MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation. J Immunol 183: 261–269. · DOI · Paper page
  25. Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E . (2008). Chemotherapy for recurrent cervical cancer. Cancer Treat Rev 34: 603–613. · DOI
  26. Petit T, Bearss DJ, Troyer DA, Munoz RM, Windle JJ . (2003). p53-independent response to cisplatin and oxaliplatin in MMTV-ras mouse salivary tumors. Mol Cancer Ther 2: 165–171.
  27. Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V et al. (2005). Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 65: 6282–6293. · DOI · Paper page
  28. Schulze A, Nicke B, Warne PH, Tomlinson S, Downward J . (2004). The transcriptional response to Raf activation is almost completely dependent on mitogen-activated protein kinase kinase activity and shows a major autocrine component. Mol Biol Cell 15: 3450–3463. · DOI · Paper page
  29. Schweyer S, Soruri A, Meschter O, Heintze A, Zschunke F, Miosge N et al. (2004). Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br J Cancer 91: 589–598. · DOI
  30. Sheridan C, Brumatti G, Martin SJ . (2008). Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim. J Biol Chem 283: 22128–22135. · DOI · Paper page
  31. Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A et al. (2003). Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17: 2233–2238. · DOI · Paper page
  32. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD et al. (1999). Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144: 281–292. · DOI · Paper page
  33. Taylor RC, Cullen SP, Martin SJ . (2008). Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231–241. · DOI · Paper page
  34. von Kriegsheim A, Baiocchi D, Birtwistle M, Sumpton D, Bienvenut W, Morrice N et al. (2009). Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol 11: 1458–1464. · DOI · Paper page
  35. Wang X, Martindale JL, Holbrook NJ . (2000). Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435–39443. · DOI · Paper page
  36. Willis SN, Adams JM . (2005). Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17: 617–625. · DOI · Paper page
  37. Wolf D, Rotter V . (1985). Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82: 790–794. · DOI · Paper page
  38. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331. · DOI · Paper page
  39. Zhai D, Jin C, Satterthwait AC, Reed JC . (2006). Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins. Cell Death Differ 13: 1419–1421. · DOI · Paper page

Cited by

See all 71

Metadata

Authors
Sheridan, C., Brumatti, G., Elgendy, M., Brunet, M., & Martin, S. J.
Venue
Oncogene
Published
2010-08-30
Volume
29
Issue
49
Pages
6428-6441
ISSN
  • 0950-9232
  • 1476-5594
Cited by
71
References
10
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.